Telcare
Telcare developed a cellular M2M remote diabetes management platform with biometric monitoring, health coaching, and population health tools. Founded in 2008, acquired by BioTelemetry in 2016, and now part of Philips Ambulatory Monitoring & Diagnostics.
- Company typePrivate
- Founded1994
- HeadquartersMalvern, United States
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
What Telcare does
Telcare, founded in 2008 by Joachim Schoss and headquartered in Malvern, Pennsylvania, developed a machine-to-machine (M2M) cellular platform for remote chronic disease management, initially targeting diabetes and later extending to hypertension and chronic heart failure. The company's flagship product, the Telcare Remote Diabetes Management Platform, combined cellular- and web-connected biometric monitoring with proactive and reactive health coaching, population health reporting, and customizable interventions, and notably incorporated an Alexa Skill for voice-based interactions. The technology stack was anchored on proprietary M2M cellular connectivity designed to wirelessly link patients and physicians, reducing friction in chronic care delivery and enabling near real-time data flow outside of clinical settings. Telcare operated with 101-250 employees and raised approximately $63.46 million across four funding rounds between 2010 and 2014, with investors including Sequoia Capital, Norwest, Qualcomm Ventures, and Mosaic Health Solutions.
In July 2016, BioTelemetry, Inc. acquired Telcare's Remote Diabetes Management Platform, absorbing Telcare into its connected health portfolio alongside its core cardiac telemetry business. BioTelemetry was itself acquired by Royal Philips in February 2021 for approximately USD 2.8 billion, at which point Telcare became part of Philips' Connected Care segment under the Philips Ambulatory Monitoring & Diagnostics (AM&D) umbrella. Within AM&D, Telcare's diabetes and chronic care capabilities were complemented and extended by BioTelemetry's later acquisitions, including the July 2020 acquisition of the On.Demand RPM platform from Centene subsidiary Envolve People Care, which made BioTelemetry the exclusive provider of diabetes RPM services to Centene Medicaid members. As an independent operating entity, Telcare has not existed since 2016; its platform and capabilities continue as a product line within Philips AM&D alongside MCOT, ePatch, Remote INR, and EMR integration services across Epic, Cerner, and other major hospital systems.
Telcare firmographics
Firmographics- Name
- Telcare
- Legal name
- BioTelemetry, Inc.
- Website
- https://gobio.com
- Company type
- Private
- Founded year
- 1994
- Operating status
- Acquired
- Headcount range
- 101–250 employees
- Short description
- Telcare developed a cellular M2M remote diabetes management platform with biometric monitoring, health coaching, and population health tools. Founded in 2008, acquired by BioTelemetry in 2016, and now part of Philips Ambulatory Monitoring & Diagnostics.
- Ownership category
- akta.pro rank
Telcare industry classification
Industry- Product category
- Remote Patient Monitoring Software
- NAICS
- Services for the Elderly and Persons with Disabilities (624120), Services for the Elderly and Persons with Disabilities (62412)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Endocrinology & Diabetes Telemedicine Platforms (HLALAGAD)
- akta.pro secondary industries
- Chronic Condition Management & Remote Monitoring (e.g., diabetes, HTN) (HLALADAD), Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)
Keywords
Where Telcare is headquartered
LocationHeadquarters
- HQ city
- Malvern
- HQ country
- United States
- HQ region
- North America
Markets served
Telcare business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Telcare product offering
Product offeringCore offering
Telcare develops a Remote Diabetes Management Platform that combines machine-to-machine (M2M) cellular technology with biometric monitoring devices, web- and mobile-based software, proactive and reactive health coaching, population health reporting, and customizable clinical interventions for diabetes, hypertension, and chronic heart failure. The platform enables real-time data transmission from patient devices to physicians for clinical decision-making and supports voice-based interaction via an Alexa Skill.
Product overview
Telcare operates as a product line within Philips Ambulatory Monitoring & Diagnostics (formerly BioTelemetry, Inc.), a connected health technology company providing remote cardiac diagnostics, diabetes management, and population health monitoring. The portfolio centers on two flagship cardiac monitoring products: Philips Mobile Cardiac Telemetry (MCOT) offering up to 30 days of continuous 2-channel ECG monitoring with AI-powered SmartDetect arrhythmia detection, and Philips Extended Holter (ePatch) providing 3-14 day continuous Holter recording with Philips medical-grade AI analytics. These are complemented by the Remote INR self-testing platform for warfarin patients, EMR integration services connecting cardiac monitoring data to hospital systems (Epic, Cerner, Allscripts, Philips IntelliSpace ECG, Muse, Geneva Health Solutions, eClinical Works, NextGen, Athena, Epiphany Healthcare, Meditech), the Geneva Healthcare implantable device management platform, and On.Demand RPM coaching for diabetes, hypertension, and heart failure. The Telcare Remote Diabetes Management Platform (acquired 2016) provides mHealth monitoring combining biometric data with coaching interventions. The Boston Scientific LUX-Dx Insertable Cardiac Monitor extends the portfolio to insertable devices. The architecture is a platform-plus-services model where MCOT and ePatch serve as primary monitoring devices, EMR integration provides data delivery infrastructure, and supplementary products address specific care pathways (stroke, post-TAVR, ED discharge, AF ablation, PCP-cardiology collaboration).
Differentiator
Problem solved
Functional benefit
Brands
- MCOT (Mobile Cardiac Outpatient Telemetry): Mobile cardiac telemetry monitoring system for arrhythmia detection with FDA clearance and up to 30 days of monitoring capability
- ePatch (Extended Holter)
- Remote INR
- BioTel Heart
- BioTel Heart EMR Integration
Products and services
- Telcare Remote Diabetes Management Platform An mHealth platform combining real-time biometric monitoring with cellular- and web-based technology, proactive and reactive health coaching, population health reporting, and customizable interventions for diabetes, hypertension, and chronic heart failure, including an Alexa Skill for voice-based interactions. Acquired by BioTelemetry in July 2016 and operating today as Telcare Medical Supply, LLC within Philips AM&D.
Companies that use Telcare
Customer profileIdeal customer profiles2 records
Telcare technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration13 records
AI capability6 records
Telcare partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- BioTelemetry, Inc.coreIn July 2016, BioTelemetry, Inc. announced the acquisition of Telcare's Remote Diabetes Management Platform. This acquisition expanded BioTelemetry's connected health portfolio, adding chronic remote patient monitoring and coaching solutions focused on diabetes, hypertension, and chronic heart failure. Telcare became part of the BioTelemetry family and subsequently Philips following the 2021 acquisition.
Recent moves5 records
Expansion highlights5 records
Telcare competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Telcare social profiles
Digital presenceTelcare compliance and trust
Trust signalCompliance1 record
Telcare financial estimates
Financial estimateRevenue estimate
Valuation estimate
Telcare leadership team
Management profileNumber of profiles
Telcare subsidiaries and ownership
Company hierarchySubsidiaries6 records
Telcare funding detail
Funding detailFunding overview
Funding rounds4 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Telcare M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Telcare
What does Telcare do?
Telcare develops a Remote Diabetes Management Platform that combines machine-to-machine (M2M) cellular technology with biometric monitoring devices, web- and mobile-based software, proactive and reactive health coaching, population health reporting, and customizable clinical interventions for diabetes, hypertension, and chronic heart failure. The platform enables real-time data transmission from patient devices to physicians for clinical decision-making and supports voice-based interaction via an Alexa Skill.
Is Telcare a public or private company?
Telcare is a private company. It is classified as corporate owned and is currently acquired.
When was Telcare founded?
Telcare was founded in 1994. It employs 101 to 250 people.
Where is Telcare based?
Telcare is headquartered in Malvern, United States, in the North America region.
Does Telcare have an API?
No public API is recorded for Telcare.
What industry is Telcare in?
Telcare's product category is Remote Patient Monitoring Software. Its primary akta.pro industry code is HLALAGAD, Endocrinology & Diabetes Telemedicine Platforms, with a secondary code of HLALADAD, Chronic Condition Management & Remote Monitoring (e.g., diabetes, HTN). Its NAICS code is 624120 and its SIC code is 3845.